Soluble Interleukin-2 Receptor and Tumor Necrosis Factor Levels in Depressed Patients in Estonia

Medicina - Lithuania
doi 10.3390/medicina45120124
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

MDPI AG

Related search

Soluble Tumor Necrosis Factor Receptor Type I Enhances Tumor Development and Persistence in Vivo

Cellular Immunology
Immunology
2000English

CrmE, a Novel Soluble Tumor Necrosis Factor Receptor Encoded by Poxviruses

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2001English

Soluble Tumor Necrosis Factor Receptor 1 and 2 Predict Outcomes in Advanced Chronic Kidney Disease: A Prospective Cohort Study

PLoS ONE
Multidisciplinary
2015English

Presence of Circulating Levels of Interferon-G, Interleukin-10 and Tumor Necrosis Factor-A in Patients With Visceral Leishmaniasis

Revista do Instituto de Medicina Tropical de Sao Paulo
MedicineInfectious Diseases
1998English

Soluble Interleukin 2 Receptor in Patients With Chronic Hepatitis Type B.

Acta Hepatologica Japonica
Hepatology
1988English

Soluble Interleukin 2 Receptor and Interleukin 1α in Toxic Epidermal Necrolysis

Archives of Dermatology
2002English

The Relationship Between Soluble Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Levels and Cardiac Functions in Peritoneal Dialysis Patients

European Journal of Inflammation
AllergyImmunology
2014English

Treatment Effects Upon Prolactin and Soluble Receptor of Interleukin-2 in Psoriatic Patients

MAEDICA – a Journal of Clinical Medicine
2018English

Studies on the Soluble Interleukin-2 Receptor in Patients With Bronchial Asthma

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy